Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000068.xml
Semin intervent Radiol 2003; 20(4): 307-322
DOI: 10.1055/s-2004-828942
DOI: 10.1055/s-2004-828942
Lung Radiofrequency Ablation
Further Information
Publication History
Publication Date:
20 July 2004 (online)
ABSTRACT
Lung cancer is the leading cause of death among men and women in the United States. Utilizing the best current therapies results in an overall 5-year relative survival rate of 15% for all stages, necessitating the use of alternative therapies. Radiofrequency ablation (RFA) is an expanding modality for the local control of non-small cell lung cancer (NSCLC). The technique and application of RFA in pulmonary neoplasms will be discussed in addition to early clinical experience.
KEYWORDS
Radiofrequency ablation - pulmonary - non-small cell lung cancer
REFERENCES
- 1 Parkin D M, Sasco A J. Lung cancer: worldwide variation in occurrence and proportion attributable to tobacco use. Lung Cancer . 1993; 9 1-16
-
2 American Cancer Society. Cancer Facts & Figures 2003. Atlanta, GA: American Cancer Society; 2003
- 3 Mountain C F. Revisions in the international system for staging lung cancer. Chest . 1997; 111 1710-1717
- 4 Van Rens M, de la Riviere A B, Elbers H RJ. et al . Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest . 2000; 117 374-379
- 5 Murai N, Koga K, Nagamachi S. et al . Radiotherapy in bone metastses, with special reference to its effect on relieving pain. Gan No Rinsho . 1989; 35 1149-1152
- 6 Highland A M, Mack P, Breen D J. Radiofrequency thermal ablation of a metastatic lung nodule. Eur Radiol . 2002; l4(suppl) S166-S170
- 7 Rajdev L, Keller S M. Neoadjuvant and adjuvant therapy of non-small cell lung cancer. Surg Oncol . 2002; 11 243-253
- 8 Rudd R. Chemotherapy in the treatment of non-small cell lung cancer. Respiratory Disease in Practice . 1991; 7 12-14
-
9 Macbeth F, Toy E, Coles B. et al .Palliative radiotherapy regimens for non-small cell lung cancer (Cochrane Review). In: The Cochrane Library, Issue 3, 2003 Oxford: Update software:www.update-software.com/cochrane/userGuide.pdf
- 10 D'Amico T. Local control without resection. J Thorac Cardiovasc Surg . 2003; 125 787-788
- 11 Ginsberg R J, Rubinstein L V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg . 1995; 60 615-623
- 12 Morrison R, Deeley T J, Cleland W P. The treatment of carcinoma of the bronchus: a clinical trial to compare surgery and supervoltage radiotherapy. Lancet . 1963; i 683-684
-
13 Rowell N P, Williams C J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable) (Cochrane Review). In: The Cochrane Library, Issue 3, 2003 Oxford: update software:www.update-software.com/cochrane/userGuide.pdf
-
14 Non-small Cell Lung Cancer Collaborative Group. Chemotherapy for non-small cell lung cancer (Cochrane Review). In: The Cochrane Library, Issue 3, 2003 Oxford: Update software:www.update-software.com/cochrane/userGuide.pdf
- 15 Dupuy D E, Zagoria R J, Akerley W. et al . Percutaneous radiofrequency ablation of malignancies in the lung. AJR . 2000; 174 57-59
- 16 Goldberg S N, Dupuy D E. Image-guided radiofrequency tumor ablation: challenges and opportunities - part I. J Vasc Interv Radiol . 2001; 12 1021-1032
- 17 Dupuy D E, Goldberg S N. Image-guided radiofrequency tumor ablation: challenges and opportunities - part II. J Vasc Interv Radiol . 2001; 12 1135-1148
- 18 Rose S C, Fotoohi M, Levin D L. et al . Cerebral microembolization during radiofrequency ablation of lung malignancies. J Vasc Interv Radiol . 2002; 13(10) 1051-1054
- 19 Kvale R A, Simoff M, Prakash U BS. Palliative care. Chest . 2003; 123 284S-311S
- 20 Griffin J P, Nelson J E, Koch K A. et al . End-of-life care in patients with lung cancer. Chest . 2003; 123 312S-331S
- 21 SUPPORT principal investigators. A controlled trial to improve care for seriously ill hospitalized patients. JAMA . 1995; 274 1591-1598
- 22 Watson P N, Evans R J. Intractable pain with lung cancer. Pain . 1987; 29 163-173
- 23 Langendijk J A, Ten Velde P M G, Aaronson N K. et al . Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys . 2000; 47 149-155
- 24 Dupuy D E, Mayo-Smith W W, Abbott G F, DiPetrillo T. Clinical Applications of Radio-frequency Tumor Ablation in the Thorax. Radiographics . 2002; 22 S259-S269
- 25 Jain S K, Dupuy D E, Cardarelli G A, Zheng Z, DiPetrillo T A. Percutaneous radiofrequency ablation of pulmonary malignancies:combined treatment with brachytherapy. AJR . 2003; 181 711-715
- 26 Warzelhan J, Stoelben E, Imdahl A. et al . Results in surgery for primary and metastatic chest wall tumors. Eur J Cardiothorac Surg . 2001; 19 584-588
- 27 Patti J, Neeman Z, Wood B. Radiofrequency ablation for cancer-associated pain. J Pain . 2002; 3 471-473
- 28 McCaughan B. Recent advances in managing non-small-cell lung cancer:2. Med J Aust . 1997; 166(suppl) S7-S10
- 29 Dupuy D E, Safran H, Mayo-Smith W W, Goldberg S N. Radiofrequency ablation of painful osseous metastatic disease: Scientific paper presented at the RSNA annual meeting, Chicago, IL. Radiology . 1998; 209(suppl) 171S-172S
- 30 Kapural L, Mekhail N. Radiofrequency ablation for chronic pain control. Curr Pain Headache Rep . 2001; 5 517-525
- 31 Langendijk H, de Jong J, Tywa M. et al . External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol . 2001; 58 257-268
- 32 Kishi K, Nakamura H, Sudo A. et al . Tumor debulking by radiofrequency ablation in hypertrophic pulmonary osteoarthropathy associated with pulmonary carcinoma. Lung Cancer . 2002; 38 317-320
- 33 Ohhigashi S, Nishio T, Watanabe F. et al . Experience with radiofrequency ablation in the treatment of pelvic recurrence in rectal cancer: report of two cases. Dis Colon Rectum . 2001; 44 741-745
- 34 Callstrom M R, Charboneau J W, Goetz M P. et al . Painful metastases involving bone: feasability of percutaneous CT- and US-guided radio-frequency ablation. Radiology . 2002; 224 87-97
- 35 Temple L K, Brennan M F. The role of pulmonary metastasectomy in soft tissue sarcoma. Semin Thorac Cardiovasc Surg . 2002; 14 35-44
- 36 van der Poel G H, Roukema J A, Horenblas S, van Geel N A, Debruyne F M. Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol . 1999; 35 197-203
- 37 Piltz S, Meimarakis G, Wichmann M W. et al . Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg . 2002; 73 1082-1087
- 38 Okumura S, Kondo H, Tsuboi M. et al . Pulmonary resection for metastatic colorectal cancer: experience with 159 patients. J Thorac Cardiovasc Surg . 1996; 112 867-874
- 39 Labow D M, Buell J E, Yoshida A, Rosen S, Posner M C. Isolated pulmonary recurrence after resection of colorectal hepatic metastases-is resection indicated?. Cancer J . 2002; 8 342-347
- 40 Hamy A, Baron O, Bennouna J. et al . Rsection of hepatic and pulmonary metastases in patients with colorectal cancer. Am J Clin Oncol . 2001; 24 607-609
- 41 Gauden S, Tripcony L. The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer . 2001; 32 71-79
- 42 Dekernion J B, Ramming K P, Smith R B. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol . 1978; 120 148-152
-
43 Glenn D W, Clark W, Morris D L. et al .Percutaneous radiofrequency ablation of colorectal pulmonary metastases. In: RSNA Conference 2001; November 25-30; Chicago, IL
- 44 de Baere T, Elias D, Dromain C. et al . Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR . 2001; 175 1619-1625
- 45 Hoegler D. Radiotherapy for palliation symptoms in incurable cancer. Curr Probl Cancer . 1997; 21 129-183
- 46 Todd T R. The surgical treatment of pulmonary metastases. Chest . 1997; 112 287S-290S
- 47 Pastorino U, Buyse M, Friedel G. et al . Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg . 1997; 113 37-49
- 48 Sakamoto T, Tsubota N, Ivanaga K. et al . Pulmonary resection for metastases from colorectal cancer. Chest . 2001; 119 1069-1072
- 49 Fourquier P, Regnard J, Rea S. et al . Lung metastases of renal cell carcinoma: results of surgical resection. Eur J Cardiothorac Surg . 1997; 11 17-21
- 50 Kandioler D, Kromer E, Tuchler H. et al . Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg . 1998; 65 909-912
- 51 Kang S, Luo R, Liao W. et al .Evaluation of PET in radiofrequency ablation of lung tumors. Paper presented at: The American Society of Clinical Oncology, held in Chicago, IL, May 30-June 3 Abstract (No 2738) 2003
- 52 Steinke K, Habicht J M. ThomsenS, Soler M, Jacob AL. CT-guided radiofrequecny ablation of a pulmonary metastasis followed by surgical resection. Cardiovasc Intervent Radiol . 2002; 25 543-546
- 53 Miao Y, Yicheng N, Bosmans H. et al . Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res . 2001; 99 265-271
- 54 Downey R J, Martini N, Rusch V. et al . Extent of chest wall invasion and survival in patients with lung cancer. Ann Thorac Surg . 1999; 68 188-193
- 55 Elia S, Griffo S, Gentile M. et al . Surgical treatment of lung cancer invading chest wall: a retrospective analysis of 110 patients. Eur J Cardiothorac Surg . 2001; 20 356-360
- 56 Landreneau R J, Sugarbaker D J, Mack M J. et al . Wedge resection versus lobectomy for stage 1(T1 N0 M0) non-small cell lung cancer. J Thorac Cardiovasc Surg . 1997; 113 691-698
- 57 Martini N, Bains M S, Burt M E. et al . Incidence of local recurrence and second primaries in resected stage I lung cancer. J Thorac Cardiovasc Surg . 1995; 109 120-129
- 58 Mountain C F. A new international staging system for lung cancer. Chest . 1986; 89(4 suppl) 225-233
- 59 Naruke T, Goya T, Tsuchiya R. et al . Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg . 1988; 96 440-447
- 60 Shimizu J, Watanabe Y, Oda M. et al . Results of surgical treatment of stage I lung cancer. Nippon Geka Gakkai Zasshi . 1993; 94 505-510
- 61 Williams D E, Pairolero P C, Danis C S. et al . Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg . 1981; 82 70-76
- 62 Herrera L J, Fernando H C, Perry Y. et al . Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg . 2003; 125 929-937
- 63 Lencioni R A, Crocetti L, Cioni R. et al .Percutaneous radiofrequency thermal ablation of non-small-cell lung cancer. Paper presented at: The American Society of Clinical Oncology held in Chicago, IL, May 30-June 3 Abstract (No 2655). 2003
- 64 Dupuy D, Chauhan B, Ready N. et al .Radiofrequency ablation (RFA) followed by conventional radiotherapy (RT) for inoperable non-small cell lung cancer (NSCLC). Paper presented at: The American Society of Clinical Oncology, held in Chicago, IL, May 30-June 3 Abstract (No 2632). 2003
- 65 Martini N. Surgical treatment of non-small cell lung cancer by stage. Semin Surg Oncol . 1990; 6 248-254
- 66 Kodama K, Doi O, Higashiymama M. et al . Intentional limited resection for selected patients with T1 N0 non-small cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg . 1997; 114 347-353
- 67 Okada M, Yoshikawa K, Hatta T. et al . Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller?. Ann Thorac Surg . 2001; 71 956-960
- 68 Okamoto Y, Murakami M, Yoden E. et al . Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys . 2002; 52 390-396
- 69 Ramsey S D, Peacock S, Goodman G. et al .Prevalence of older patients with advanced non-small cell lung cancer receiving no treatment: evidence from the SEER-Medicare database. Paper presented at: The American Society of Clinical Oncology, held in Chicago, IL, May 30-June 3 Abstract (No 2586). 2003